Literature DB >> 17659936

Relation of QRS duration to mortality in a community-based cohort with hypertrophic cardiomyopathy.

Sergio Bongioanni1, Francesca Bianchi, Alessandro Migliardi, Roberto Gnavi, Paolo Giay Pron, Marzia Casetta, Maria Rosa Conte.   

Abstract

A prolonged QRS duration on the standard electrocardiogram is associated with an increased risk of cardiovascular death in cardiomyopathies of different origin. However, the relation between QRS duration and prognosis in hypertrophic cardiomyopathy (HC) remains undefined. We assessed the relation between QRS duration and cardiovascular death in 241 consecutive patients with HC. The study cohort was divided into 2 groups according to QRS duration: <120 and > or =120 ms. Of the 241 patients, 191 (79%) had a QRS duration <120 ms and 50 (21%) a QRS duration > or =120 ms. During a mean follow-up of 7.9 +/- 5.1 years, 35 patients died of cardiovascular causes related to HC. Of these 35 patients, 13 (6%) had a QRS duration <120 ms and 22 (43%) had a QRS duration > or =120 ms (p <0.01). Risk of cardiovascular death was significantly higher in patients with a QRS duration > or =120 ms than in those with a QRS duration <120 ms (relative risk 5.2, p <0.0001). At 8-year follow-up, cumulative risks of HC-related death were 7.1% in patients with a QRS duration <120 ms and 55% in those with a QRS duration > or =120 ms. Multivariate analysis confirmed that a QRS duration > or =120 ms was independently associated with an increased risk of cardiovascular death (hazard ratio 3.2, p = 0.007). New York Heart Association functional class III/IV was the only other clinical variable significantly and independently associated with an increased risk of cardiovascular death. In conclusion, in patients with HC, QRS duration on standard electrocardiogram is directly related to cardiovascular mortality, and a QRS duration > or =120 ms is a strong and independent predictor of prognosis.

Entities:  

Mesh:

Year:  2007        PMID: 17659936     DOI: 10.1016/j.amjcard.2007.03.049

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Ventricular conduction and long-term heart failure outcomes and mortality in African Americans: insights from the Jackson Heart Study.

Authors:  Robert J Mentz; Melissa A Greiner; Adam D DeVore; Shannon M Dunlay; Gaurav Choudhary; Tariq Ahmad; Prateeti Khazanie; Tiffany C Randolph; Michael E Griswold; Zubin J Eapen; Emily C O'Brien; Kevin L Thomas; Lesley H Curtis; Adrian F Hernandez
Journal:  Circ Heart Fail       Date:  2014-12-30       Impact factor: 8.790

2.  [ECG diagnostics in competitive athletes. Current implications for preparticipation screening].

Authors:  A Preßler; M Halle
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

3.  QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study.

Authors:  Matthew G Whitbeck; Richard J Charnigo; Jignesh Shah; Gustavo Morales; Steve W Leung; Brandon Fornwalt; Alison L Bailey; Khaled Ziada; Vincent L Sorrell; Milagros M Zegarra; Jenks Thompson; Neil Aboul Hosn; Charles L Campbell; John Gurley; Paul Anaya; David C Booth; Luigi Di Biase; Andrea Natale; Susan Smyth; David J Moliterno; Claude S Elayi
Journal:  Europace       Date:  2013-12-23       Impact factor: 5.214

4.  Prolonged electrocardiogram QRS duration independently predicts long-term mortality in patients hospitalized for heart failure with preserved systolic function.

Authors:  Scott L Hummel; Stephen Skorcz; Todd M Koelling
Journal:  J Card Fail       Date:  2009-04-25       Impact factor: 5.712

5.  Surface fragmented QRS in a patient with hypertrophic cardiomyopathy and malignant arrhythmias: Is there an association?

Authors:  Francisco Femenía; Mauricio Arce; Martín Arrieta; Adrian Baranchuk
Journal:  J Cardiovasc Dis Res       Date:  2012-01

6.  Association between Progressive Intraventricular Conduction Disturbance and Cardiovascular Events.

Authors:  Hideki Hayashi; Qi Wu; Minoru Horie
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

7.  Assessment of cardiac resynchronisation therapy in patients with wide QRS and non-specific intraventricular conduction delay: rationale and design of the multicentre randomised NICD-CRT study.

Authors:  Romain Eschalier; Sylvain Ploux; Bruno Pereira; Nicolas Clémenty; Antoine Da Costa; Pascal Defaye; Stéphane Garrigue; Jean-Baptiste Gourraud; Daniel Gras; Benoît Guy-Moyat; Christophe Leclercq; Pierre Mondoly; Pierre Bordachar
Journal:  BMJ Open       Date:  2016-11-11       Impact factor: 2.692

8.  Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6.

Authors:  Bram P Prins; Timothy J Mead; Jennifer A Brody; Gardar Sveinbjornsson; Ioanna Ntalla; Nathan A Bihlmeyer; Marten van den Berg; Jette Bork-Jensen; Stefania Cappellani; Stefan Van Duijvenboden; Nikolai T Klena; George C Gabriel; Xiaoqin Liu; Cagri Gulec; Niels Grarup; Jeffrey Haessler; Leanne M Hall; Annamaria Iorio; Aaron Isaacs; Ruifang Li-Gao; Honghuang Lin; Ching-Ti Liu; Leo-Pekka Lyytikäinen; Jonathan Marten; Hao Mei; Martina Müller-Nurasyid; Michele Orini; Sandosh Padmanabhan; Farid Radmanesh; Julia Ramirez; Antonietta Robino; Molly Schwartz; Jessica van Setten; Albert V Smith; Niek Verweij; Helen R Warren; Stefan Weiss; Alvaro Alonso; David O Arnar; Michiel L Bots; Rudolf A de Boer; Anna F Dominiczak; Mark Eijgelsheim; Patrick T Ellinor; Xiuqing Guo; Stephan B Felix; Tamara B Harris; Caroline Hayward; Susan R Heckbert; Paul L Huang; J W Jukema; Mika Kähönen; Jan A Kors; Pier D Lambiase; Lenore J Launer; Man Li; Allan Linneberg; Christopher P Nelson; Oluf Pedersen; Marco Perez; Annette Peters; Ozren Polasek; Bruce M Psaty; Olli T Raitakari; Kenneth M Rice; Jerome I Rotter; Moritz F Sinner; Elsayed Z Soliman; Tim D Spector; Konstantin Strauch; Unnur Thorsteinsdottir; Andrew Tinker; Stella Trompet; André Uitterlinden; Ilonca Vaartjes; Peter van der Meer; Uwe Völker; Henry Völzke; Melanie Waldenberger; James G Wilson; Zhijun Xie; Folkert W Asselbergs; Marcus Dörr; Cornelia M van Duijn; Paolo Gasparini; Daniel F Gudbjartsson; Vilmundur Gudnason; Torben Hansen; Stefan Kääb; Jørgen K Kanters; Charles Kooperberg; Terho Lehtimäki; Henry J Lin; Steven A Lubitz; Dennis O Mook-Kanamori; Francesco J Conti; Christopher H Newton-Cheh; Jonathan Rosand; Igor Rudan; Nilesh J Samani; Gianfranco Sinagra; Blair H Smith; Hilma Holm; Bruno H Stricker; Sheila Ulivi; Nona Sotoodehnia; Suneel S Apte; Pim van der Harst; Kari Stefansson; Patricia B Munroe; Dan E Arking; Cecilia W Lo; Yalda Jamshidi
Journal:  Genome Biol       Date:  2018-07-17       Impact factor: 13.583

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.